- Phase II trial of sunitinib in patients with metastatic non-clear cell renal cell carcinoma. Investigational new drugs. 2012 Academic Article GET IT
- Nephrotoxicities associated with the use of tyrosine kinase inhibitors: a single-center experience and review of the literature. Nephron. Clinical practice. 2011 Academic Article GET IT
Systemic therapy for metastatic renal cell carcinoma.
The Urologic clinics of North America.
Times cited: 31